NELSEN ROBERT
Insider CIK 1219042 · PI 10% owner · XCOM 10% owner · BLUE 10% owner · AKAO 10% owner · NGSX Director, 10% owner · IOTS 10% owner · PZRX 10% owner · FATE Director, 10% owner · KYTH Director, 10% owner · AGIO Director, 10% owner · UBX Director, 10% owner · RCPT 10% owner · QTRX 10% owner · MASS 10% owner · SYRS Director, 10% owner · PULM 10% owner · TWST 10% owner · JUNO Director, 10% owner · SAGE Director, 10% owner · BLPH Director, 10% owner · MTCR 10% owner · SNNA Director, 10% owner · CDAK 10% owner · FIXX 10% owner · VIR Director, 10% owner · DNLI Director, 10% owner · SRRK 10% owner · GOSS 10% owner · BEAM Director, 10% owner · ERAS 10% owner · SANA Director, 10% owner · KRTX Director, 10% owner · BOLD 10% owner · LYEL Director, 10% owner · VERV 10% owner · DALS 10% owner · NMRA 10% owner · PRME Director, 10% owner · RAPP 10% owner · MTSR Director, 10% owner · SPTX 10% owner · KARD Director, 10% owner · ASPE 10% owner · CTY Director, 10% owner · VBIV 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 214,355 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 259,948 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 187,182 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | P Buy | 2026-11-02 | 2026-11-02 | 1,200,000 | $15.00 | $18.00M | 1,200,000 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 214,355 | — | — | 1,161,074 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 946,719 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 651,229 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 364,925 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | P Buy | 2026-11-02 | 2026-11-02 | 66,667 | $15.00 | $1.00M | 66,667 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 259,948 | — | — | 1,393,848 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 1,133,900 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 838,410 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 552,106 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 187,182 | — | — | 253,848 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | P Buy | 2026-11-02 | 2026-11-02 | 66,666 | $15.00 | $1000.0K | 66,666 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 1,845,585 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 4,991,633 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | P Buy | 2026-10-19 | 2026-10-19 | 170,000 | $18.00 | $3.06M | 13,692,507 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion | 2026-10-19 | 2026-10-19 | 2,027,006 | — | — | 13,522,507 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion | 2026-10-19 | 2026-10-19 | 5,482,309 | — | — | 11,495,501 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion | 2026-10-19 | 2026-10-19 | 3,294,900 | — | — | 6,013,192 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | A Award deriv | 2026-10-15 | 2026-10-19 | 22,649 | — | $0 | 22,649 | SEC↗ |
| BOLD Boundless Bio, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-06 | 16,000 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | S Sale | 2026-07-01 | 2026-07-06 | 16,000 | $2.49 | $39.8K | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | M Exercise | 2026-07-01 | 2026-07-06 | 16,000 | $1.03 | $16.5K | 16,000 | SEC↗ |
| KARD Kardigan, Inc. | P Buy | 2026-06-22 | 2026-06-24 | 1,250,000 | $16.00 | $20.00M | 15,042,035 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 1,204,000 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 5,148,587 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 2,306,401 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion | 2026-06-17 | 2026-06-22 | 13,792,035 | — | $0 | 13,792,035 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion deriv | 2026-05-04 | 2026-05-04 | 2,513,686 | — | $0 | 0 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion deriv | 2026-05-04 | 2026-05-04 | 2,681,265 | — | $0 | 0 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion | 2026-05-04 | 2026-05-04 | 2,513,686 | — | $0 | 2,513,686 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion | 2026-05-04 | 2026-05-04 | 2,681,265 | — | $0 | 5,194,951 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | P Buy | 2026-05-04 | 2026-05-04 | 1,100,000 | $18.00 | $19.80M | 6,294,951 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | P Buy | 2026-03-06 | 2026-03-09 | 488,090 | $25.61 | $12.50M | 1,426,528 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-14 | 18,503,128 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-14 | 8,313,680 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2025-10-27 | 2025-10-29 | 1,915,700 | $2.61 | $5.00M | 6,046,907 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-08-01 | 2025-08-05 | 39,062 | — | $0 | 39,062 | SEC↗ |
| PRME Prime Medicine, Inc. | D To issuer deriv | 2025-08-01 | 2025-08-05 | 45,000 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | D To issuer deriv | 2025-08-01 | 2025-08-05 | 39,062 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-08-01 | 2025-08-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2025-08-01 | 2025-08-01 | 3,030,300 | $3.30 | $10.00M | 6,230,300 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 80,000 | — | $0 | 80,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 19,933,333 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion | 2025-02-03 | 2025-02-03 | 7,523,682 | — | $0 | 7,523,682 | SEC↗ |
| MTSR Metsera, Inc. | P Buy | 2025-02-03 | 2025-02-03 | 1,432,224 | $18.00 | $25.78M | 18,503,128 | SEC↗ |
| MTSR Metsera, Inc. | P Buy | 2025-02-03 | 2025-02-03 | 789,998 | $18.00 | $14.22M | 8,313,680 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion | 2025-02-03 | 2025-02-03 | 16,006,949 | — | $0 | 17,070,904 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2024-06-14 | 2024-06-17 | 130,000 | — | $0 | 130,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 45,000 | — | $0 | 45,000 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion deriv | 2024-06-10 | 2024-06-10 | 20,000,000 | — | $0 | 0 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion deriv | 2024-06-10 | 2024-06-10 | 11,924,138 | — | $0 | 0 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion | 2024-06-10 | 2024-06-10 | 3,728,738 | — | $0 | 3,728,738 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-06-06 | 2024-07-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 54,278 | — | $0 | 54,278 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2024-05-30 | 2024-06-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2024-05-30 | 2024-06-03 | 8,000 | — | $0 | 584,148 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 424,908 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 586,080 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 454,212 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 227,920 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 164,835 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 201,465 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 366,301 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | P Buy | 2024-04-02 | 2024-04-04 | 66,667 | $16.00 | $1.07M | 683,759 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 1,048,433 | — | $0 | 1,048,433 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 787,545 | — | $0 | 828,570 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 589,743 | — | $0 | 617,092 | SEC↗ |
| BOLD Boundless Bio, Inc. | P Buy | 2024-04-02 | 2024-04-04 | 133,333 | $16.00 | $2.13M | 1,181,766 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2024-02-15 | 2024-02-20 | 3,200,000 | $6.25 | $20.00M | 3,200,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 363,637 | $5.50 | $2.00M | 10,667,387 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 727,272 | $5.50 | $4.00M | 12,446,022 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 727,272 | $5.50 | $4.00M | 12,446,022 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 1,176,593 | — | $0 | 2,321,566 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 703,061 | — | $0 | 1,387,228 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-14 | 2023-11-15 | 3,357 | $11.98 | $40.2K | 4,131,207 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-13 | 2023-11-15 | 31,653 | $11.75 | $371.9K | 4,127,850 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-10 | 2023-11-13 | 5,431 | $11.75 | $63.8K | 4,096,197 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-10 | 2023-11-13 | 11,844 | $11.37 | $134.7K | 4,090,766 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-09 | 2023-11-13 | 31,079 | $10.53 | $327.3K | 4,078,922 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-08 | 2023-11-13 | 69,127 | $10.78 | $745.2K | 4,024,719 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-08 | 2023-11-13 | 23,124 | $11.79 | $272.6K | 4,047,843 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-07 | 2023-11-07 | 30,192 | $11.50 | $347.2K | 3,955,592 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-06 | 2023-11-07 | 43,082 | $11.55 | $497.6K | 3,925,400 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-03 | 2023-11-07 | 22,420 | $11.38 | $255.1K | 3,882,318 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-29 | 2023-09-29 | 34,560 | $13.98 | $483.1K | 3,859,898 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-28 | 2023-09-29 | 25,110 | $13.69 | $343.8K | 3,825,338 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-28 | 2023-09-29 | 16,841 | $13.06 | $219.9K | 3,800,228 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-27 | 2023-09-27 | 24,504 | $12.31 | $301.6K | 3,783,387 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-26 | 2023-09-27 | 34,000 | $11.73 | $398.8K | 3,758,883 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-25 | 2023-09-25 | 29,967 | $11.65 | $349.1K | 3,724,883 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-25 | 2023-09-25 | 30,773 | $10.80 | $332.3K | 3,694,916 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-22 | 2023-09-25 | 40,000 | $11.14 | $445.6K | 3,664,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-19 | 2023-09-20 | 1,500,000 | $17.00 | $25.50M | 3,624,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 684,167 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 1,144,973 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 12,205,379 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 2,124,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 11,886,758 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2023-09-08 | 2023-09-08 | 55,000 | — | $0 | 55,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | J Other | 2023-07-28 | 2023-08-10 | 1,600,000 | — | $0 | 0 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2023-06-16 | 2023-06-20 | 65,000 | — | $0 | 65,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 39,062 | — | $0 | 39,062 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 65,000 | — | $0 | 65,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2023-05-22 | 2023-05-24 | 12,054 | — | $0 | 12,054 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2023-05-22 | 2023-05-24 | 6,027 | — | $0 | 576,148 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2023-01-05 | 2023-01-06 | 536 | — | $0 | 1,353 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 1,141,474 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 1,141,474 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 16,666,664 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 16,666,667 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 49,999 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 16,080 | — | $0 | 16,080 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2022-10-24 | 2022-10-26 | 400,000 | $17.00 | $6.80M | 6,128,297 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2022-10-24 | 2022-10-26 | 400,000 | $17.00 | $6.80M | 6,128,297 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 5,728,297 | — | $0 | 5,728,297 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 5,728,297 | — | $0 | 5,728,297 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2022-10-05 | 2022-10-06 | 321 | — | $0 | 817 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy deriv | 2022-09-13 | 2022-09-15 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2022-09-13 | 2022-09-15 | 5,000,000 | $1.50 | $7.50M | 8,854,098 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-06 | 2022-09-07 | 239,559 | — | $0 | 5,626,008 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-06 | 2022-09-07 | 30,238 | — | $0 | 570,121 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-06 | 2022-09-07 | 1,850 | — | $0 | 33,893 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-06 | 2022-09-07 | 310,441 | — | $0 | 7,290,655 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-02 | 2022-09-07 | 196,003 | — | $0 | 5,865,567 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-02 | 2022-09-07 | 253,997 | — | $0 | 7,601,096 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-02 | 2022-09-07 | 24,737 | — | $0 | 539,883 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-02 | 2022-09-07 | 1,508 | — | $0 | 32,043 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-31 | 2022-09-01 | 217,781 | — | $0 | 6,061,570 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-31 | 2022-09-01 | 282,219 | — | $0 | 7,855,093 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-31 | 2022-09-01 | 27,489 | — | $0 | 515,146 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-31 | 2022-09-01 | 1,684 | — | $0 | 30,535 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-30 | 2022-09-01 | 282,219 | — | $0 | 8,137,312 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-30 | 2022-09-01 | 217,781 | — | $0 | 6,279,351 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-30 | 2022-09-01 | 1,684 | — | $0 | 28,851 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-30 | 2022-09-01 | 27,489 | — | $0 | 487,657 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-25 | 2022-08-26 | 1,684 | — | $0 | 27,167 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-25 | 2022-08-26 | 27,489 | — | $0 | 460,168 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-25 | 2022-08-26 | 282,219 | — | $0 | 8,419,531 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-25 | 2022-08-26 | 217,781 | — | $0 | 6,497,132 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-24 | 2022-08-26 | 217,781 | — | $0 | 6,714,913 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-24 | 2022-08-26 | 1,684 | — | $0 | 25,483 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-24 | 2022-08-26 | 27,489 | — | $0 | 432,679 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-24 | 2022-08-26 | 282,219 | — | $0 | 8,701,750 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-18 | 2022-08-22 | 1,684 | — | $0 | 23,799 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-18 | 2022-08-22 | 27,489 | — | $0 | 405,190 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-18 | 2022-08-22 | 282,219 | — | $0 | 8,983,969 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-18 | 2022-08-22 | 217,781 | — | $0 | 6,932,694 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-16 | 2022-08-16 | 1,684 | — | $0 | 22,115 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-16 | 2022-08-16 | 27,489 | — | $0 | 377,701 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-16 | 2022-08-16 | 282,219 | — | $0 | 9,266,188 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-16 | 2022-08-16 | 217,781 | — | $0 | 7,150,475 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-15 | 2022-08-16 | 27,489 | — | $0 | 350,212 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-15 | 2022-08-16 | 282,219 | — | $0 | 9,548,407 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-15 | 2022-08-16 | 217,781 | — | $0 | 7,368,256 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-15 | 2022-08-16 | 1,684 | — | $0 | 20,431 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-12 | 2022-08-16 | 1,684 | — | $0 | 18,747 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-12 | 2022-08-16 | 27,489 | — | $0 | 322,723 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-12 | 2022-08-16 | 282,219 | — | $0 | 9,830,626 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-12 | 2022-08-16 | 217,781 | — | $0 | 7,586,037 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2022-07-05 | 2022-07-07 | 266 | — | $0 | 496 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 65,000 | — | $0 | 65,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-08 | 2022-06-10 | 282,219 | — | $0 | 10,112,845 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-08 | 2022-06-10 | 217,781 | — | $0 | 7,803,818 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-08 | 2022-06-10 | 27,489 | — | $0 | 295,234 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-08 | 2022-06-10 | 1,684 | — | $0 | 17,063 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2022-06-06 | 2022-06-08 | 65,000 | — | $0 | 65,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-02 | 2022-06-06 | 29,173 | — | $0 | 283,124 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-02 | 2022-06-06 | 282,219 | — | $0 | 10,395,064 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-02 | 2022-06-06 | 217,781 | — | $0 | 8,021,599 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2022-05-23 | 2022-05-25 | 12,810 | — | $0 | 12,810 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2022-05-23 | 2022-05-25 | 6,405 | — | $0 | 253,951 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2022-04-05 | 2022-04-06 | 230 | — | $0 | 230 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-12-20 | 2022-05-10 | 102,041 | — | $0 | 247,546 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-12-20 | 2021-12-22 | 987,767 | — | $0 | 10,677,283 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-12-20 | 2021-12-22 | 102,041 | — | $0 | 244,172 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-12-20 | 2021-12-22 | 762,233 | — | $0 | 8,239,380 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-29 | 2021-12-01 | 217,781 | — | $0 | 9,001,613 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-29 | 2021-12-01 | 29,153 | — | $0 | 142,131 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-29 | 2021-12-01 | 282,219 | — | $0 | 11,665,050 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-22 | 2021-11-24 | 217,781 | — | $0 | 9,219,394 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-22 | 2021-11-24 | 282,219 | — | $0 | 11,947,269 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-22 | 2021-11-24 | 29,153 | — | $0 | 112,978 | SEC↗ |
| DALS DA32 Life Science Tech Acq | J Other deriv | 2021-08-05 | 2021-08-09 | 701,250 | — | $0 | 4,465,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | J Other | 2021-07-30 | 2021-08-03 | 650,000 | $10.00 | $6.50M | 2,250,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | P Buy | 2021-07-30 | 2021-08-03 | 1,600,000 | $10.00 | $16.00M | 1,600,000 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 2,100,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 2,100,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 3,400,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 1,133,333 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 3,400,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 1,133,333 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 5,527,777 | — | $0 | 5,527,777 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 5,527,777 | — | $0 | 5,527,777 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-07-01 | 2021-07-06 | 2,257,752 | — | $0 | 12,229,488 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-07-01 | 2021-07-06 | 1,742,248 | — | $0 | 9,437,175 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-07-01 | 2021-07-06 | 47,897 | — | $0 | 83,825 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 200,000 | — | $0 | 2,921,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 200,000 | — | $0 | 2,921,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 4,686 | — | $0 | 28,111 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 811 | — | $0 | 4,867 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 2,555 | — | $0 | 15,328 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 200,000 | — | $0 | 3,121,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 2,555 | — | $0 | 12,773 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 4,686 | — | $0 | 23,425 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 200,000 | — | $0 | 3,121,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 811 | — | $0 | 4,056 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 4,686 | — | $0 | 18,739 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 811 | — | $0 | 3,245 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 2,555 | — | $0 | 10,218 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 200,000 | — | $0 | 3,321,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 200,000 | — | $0 | 3,321,519 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-06-22 | 2021-06-24 | 564,438 | — | $0 | 14,487,240 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-06-22 | 2021-06-24 | 11,974 | — | $0 | 35,928 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-06-22 | 2021-06-24 | 435,562 | — | $0 | 11,179,423 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 7,107,024 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 7,107,023 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 4,508,144 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 4,508,146 | — | $0 | 0 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 435,142 | — | $0 | 0 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 17,771,216 | — | $0 | 0 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 17,771,216 | — | $0 | 0 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 435,142 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 1,254,404 | — | $0 | 1,254,404 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 1,254,405 | — | $0 | 1,254,405 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 18,206,358 | — | $0 | 18,206,358 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 18,206,358 | — | $0 | 18,206,358 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-06-02 | 2021-06-04 | 6,222 | — | $0 | 6,222 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2021-06-02 | 2021-06-04 | 2,074 | — | $0 | 12,432 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-06-01 | 2021-06-03 | 3,253 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-06-01 | 2021-06-03 | 3,253 | — | $0 | 10,358 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2021-05-21 | 2021-05-25 | 6,748 | — | $0 | 6,748 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2021-05-21 | 2021-05-25 | 3,374 | — | $0 | 27,328 | SEC↗ |
| DNLI Denali Therapeutics Inc. | J Other | 2021-05-12 | 2021-06-03 | 2,537 | — | $0 | 7,105 | SEC↗ |
| DNLI Denali Therapeutics Inc. | J Other | 2021-05-12 | 2021-06-03 | 500,000 | — | $0 | 9,668,749 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2021-04-21 | 2021-04-27 | 12,500 | — | $0 | 12,500 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-04-13 | 2021-04-15 | 75,000 | — | $0 | 1,456,437 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-04-13 | 2021-04-15 | 1,756 | — | $0 | 5,269 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-04-13 | 2021-04-15 | 75,000 | — | $0 | 1,456,435 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-08 | 2021-04-09 | 282,219 | — | $0 | 15,051,678 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-08 | 2021-04-09 | 217,781 | — | $0 | 11,614,985 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-08 | 2021-04-09 | 5,989 | — | $0 | 23,954 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-07 | 2021-04-09 | 282,219 | — | $0 | 15,333,897 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-07 | 2021-04-09 | 217,781 | — | $0 | 11,832,766 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-07 | 2021-04-09 | 5,989 | — | $0 | 17,965 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-01 | 2021-04-01 | 282,219 | — | $0 | 15,616,116 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-01 | 2021-04-01 | 217,781 | — | $0 | 12,050,547 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-01 | 2021-04-01 | 5,987 | — | $0 | 11,976 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-31 | 2021-04-02 | 4,686 | — | $0 | 14,053 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-31 | 2021-04-02 | 200,000 | — | $0 | 3,521,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-31 | 2021-04-02 | 200,000 | — | $0 | 3,521,519 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-03-30 | 2021-04-01 | 282,219 | — | $0 | 15,898,335 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-03-30 | 2021-04-01 | 217,781 | — | $0 | 12,268,328 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-03-30 | 2021-04-01 | 5,989 | — | $0 | 5,989 | SEC↗ |
| DNLI Denali Therapeutics Inc. | J Other | 2021-03-22 | 2021-06-03 | 2,538 | — | $0 | 4,568 | SEC↗ |
| DNLI Denali Therapeutics Inc. | J Other | 2021-03-22 | 2021-06-03 | 500,000 | — | $0 | 10,168,749 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-22 | 2021-03-22 | 200,000 | — | $0 | 3,721,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-22 | 2021-03-22 | 4,684 | — | $0 | 9,367 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-22 | 2021-03-22 | 200,000 | — | $0 | 3,721,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-18 | 2021-03-22 | 200,000 | — | $0 | 3,921,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-18 | 2021-03-22 | 4,683 | — | $0 | 4,683 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-18 | 2021-03-22 | 200,000 | — | $0 | 3,921,519 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,375,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 5,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 3,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 3,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 2,343,750 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 2,343,750 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 781,250 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 781,250 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 5,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,375,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,718,750 | — | $0 | 11,718,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 10,156,250 | — | $0 | 10,303,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,718,750 | — | $0 | 11,718,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 10,156,250 | — | $0 | 10,301,250 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2021-02-03 | 2021-02-05 | 14,000 | — | $0 | 14,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2021-02-03 | 2021-02-18 | 23,591 | — | $0 | 23,591 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-01-08 | 2021-01-12 | 75,000 | — | $0 | 1,531,437 | SEC↗ |